Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Fici

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer ManagementPietro Fici
Frontiers in Oncology|January 27, 2017
Circulating Tumor Cells: Back to the FutureGiulia Gallerani, Pietro Fici, Francesco Fabbri
Cancer Letters|April 10, 2016
CTCs in early breast cancer: A path worth takingRoberta Maltoni, Giulia Gallerani, Pietro Fici, et al.
Clinical and Translational Medicine|May 2, 2015
Epithelial Mesenchymal Transition: a double-edged swordGuislaine Barriere, Pietro Fici, Giulia Gallerani, et al.
The Lancet. Oncology|May 3, 2019
Crowdfunding for cancer research: the TRACe campaign as an exampleGiulia Gallerani, Pietro Fici, Alessandro Coatti, et al.
Annals of Translational Medicine|December 10, 2014
Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulationsGuislaine Barriere, Pietro Fici, Giulia Gallerani, et al.
Oncotarget|December 3, 2016
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancerPietro Fici, Giulia Gallerani, Anne-Pierre Morel, et al.
Cancers|September 5, 2020
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast CancerTania Rossi, Giulia Gallerani, Davide Angeli, et al.
Cancers|August 26, 2022
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell AnalysisTania Rossi, Davide Angeli, Michela Tebaldi, et al.
Cancer Letters|February 20, 2013
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCsFrancesco Fabbri, Silvia Carloni, Wainer Zoli, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer ManagementPietro Fici
Frontiers in Oncology|January 27, 2017
Circulating Tumor Cells: Back to the FutureGiulia Gallerani, Pietro Fici, Francesco Fabbri
Cancer Letters|April 10, 2016
CTCs in early breast cancer: A path worth takingRoberta Maltoni, Giulia Gallerani, Pietro Fici, et al.
Clinical and Translational Medicine|May 2, 2015
Epithelial Mesenchymal Transition: a double-edged swordGuislaine Barriere, Pietro Fici, Giulia Gallerani, et al.
The Lancet. Oncology|May 3, 2019
Crowdfunding for cancer research: the TRACe campaign as an exampleGiulia Gallerani, Pietro Fici, Alessandro Coatti, et al.
Annals of Translational Medicine|December 10, 2014
Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulationsGuislaine Barriere, Pietro Fici, Giulia Gallerani, et al.
Oncotarget|December 3, 2016
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancerPietro Fici, Giulia Gallerani, Anne-Pierre Morel, et al.
Cancers|September 5, 2020
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast CancerTania Rossi, Giulia Gallerani, Davide Angeli, et al.
Cancers|August 26, 2022
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell AnalysisTania Rossi, Davide Angeli, Michela Tebaldi, et al.
Cancer Letters|February 20, 2013
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCsFrancesco Fabbri, Silvia Carloni, Wainer Zoli, et al.
Pageof 2